Editas Medicine (EDIT) Operating Income: 2015-2025
Historic Operating Income for Editas Medicine (EDIT) over the last 11 years, with Sep 2025 value amounting to -$24.5 million.
- Editas Medicine's Operating Income rose 62.62% to -$24.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$198.8 million, marking a year-over-year increase of 12.99%. This contributed to the annual value of -$251.2 million for FY2024, which is 48.45% down from last year.
- As of Q3 2025, Editas Medicine's Operating Income stood at -$24.5 million, which was up 52.37% from -$51.5 million recorded in Q2 2025.
- In the past 5 years, Editas Medicine's Operating Income registered a high of -$24.0 million during Q4 2023, and its lowest value of -$76.2 million during Q1 2025.
- For the 3-year period, Editas Medicine's Operating Income averaged around -$52.1 million, with its median value being -$51.0 million (2023).
- As far as peak fluctuations go, Editas Medicine's Operating Income tumbled by 536.68% in 2021, and later spiked by 62.62% in 2025.
- Over the past 5 years, Editas Medicine's Operating Income (Quarterly) stood at -$41.6 million in 2021, then plummeted by 52.48% to -$63.4 million in 2022, then surged by 62.23% to -$24.0 million in 2023, then plummeted by 94.45% to -$46.6 million in 2024, then surged by 62.62% to -$24.5 million in 2025.
- Its Operating Income was -$24.5 million in Q3 2025, compared to -$51.5 million in Q2 2025 and -$76.2 million in Q1 2025.